Search - tctmd.com

Displaying 361 - 380 of 1431

Sort: Relevancy | Date

News Daily News

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

L.A. McKeown

August 05, 2015

News Daily News

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

August 04, 2015

News Daily News

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

August 04, 2015

News Industry News

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

August 03, 2015

News Daily News

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

L.A. McKeown

August 03, 2015

News Daily News

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

July 30, 2015

News Daily News

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

L.A. McKeown

July 29, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Industry News

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

July 28, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Industry News

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

July 28, 2015

News Industry News

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

July 27, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Todd Neale

July 27, 2015

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

News Industry News

MHRA review confirms benefit-risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke

July 24, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Industry News

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

July 22, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Features

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

July 21, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

Advertisement

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

Triple Therapy Yields No Thrombotic Benefit, More Bleeding in Older PCI Patients With A-fib

El Tratamiento Triple No ofrece Beneficio Trombótico y Sí Más Hemorragias en Pacientes Ancianos con FA sometidos a PCI

Celyad Completes Final Patient Infusion in CHART-1 Phase III Trial

Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres

RITA 3 Published: Routine Invasive Strategy in NSTE-ACS Loses Advantage at 10 Years

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

Esperion Therapeutics Announces Positive Top-Line Phase 2 Results for ETC-1002 in Patients With Hypercholesterolemia and Hypertension

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

Navidea and Massachusetts General Hospital to Evaluate Manocept™ for Detection of Cardiovascular Disease with NIH Grant

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

MHRA review confirms benefit-risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

CMS Penalties Spur Efforts to Reduce 30-Day Hospital Readmissions

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content